InvestSMART

Telix Pharmaceuticals Limited (ASX: TLX) - Announcements

Current share price for TLX : $15.160 0.45 (2.88%)+

ASX company news and announcements for Telix Pharmaceuticals Limited (TLX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Telix Pharmaceuticals Limited (TLX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Telix Pharmaceuticals Limited (TLX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Telix Pharmaceuticals Limited (TLX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5,153 Cleansing Notice 27 Jul 2023 8:21AM $11.110 $15.160 risen by 36.45%
$5,153 Application for quotation of securities - TLX 27 Jul 2023 8:20AM $11.110 $15.160 risen by 36.45%
$5,153 Q2 2023 Business Update to Accompany Quarterly Results 19 Jul 2023 4:16PM $12.160 $15.160 risen by 24.67%
$5,153 Activities Report and Appendix 4C - June 2023 Quarter 19 Jul 2023 4:13PM $12.160 $15.160 risen by 24.67%
$5,153 Notification of upcoming quarterly results and investor call 13 Jul 2023 8:19AM $11.120 $15.160 risen by 36.33%
$5,153 Notification of cessation of securities - TLX 10 Jul 2023 8:21AM $10.510 $15.160 risen by 44.24%
$5,153 Notification regarding unquoted securities - TLX 10 Jul 2023 8:20AM $10.510 $15.160 risen by 44.24%
$5,153 Cleansing Notice 28 Jun 2023 8:23AM $11.320 $15.160 risen by 33.92%
$5,153 Application for quotation of securities - TLX 28 Jun 2023 8:23AM $11.320 $15.160 risen by 33.92%
$5,153 Proposed issue of securities - TLX 21 Jun 2023 6:12PM $12.280 $15.160 risen by 23.45%
$5,153 Lightpoint Acquisition to Expand Telix Urologic Pipeline 21 Jun 2023 6:11PM $12.280 $15.160 risen by 23.45%
$5,153 Telix Urology Innovation Showcase 21 Jun 2023 8:22AM $11.610 $15.160 risen by 30.58%
$5,153 Phase II study for indication expansion of TLX250-CDx doses 19 Jun 2023 8:30AM $11.410 $15.160 risen by 32.87%
$5,153 Appendix 3Y Change in Director Interests - C Behrenbruch 2 Jun 2023 8:20AM $11.660 $15.160 risen by 30.02%
$5,153 Notification regarding unquoted securities - TLX 2 Jun 2023 8:20AM $11.660 $15.160 risen by 30.02%
$5,153 Cleansing Notice 2 Jun 2023 8:20AM $11.660 $15.160 risen by 30.02%
$5,153 Application for quotation of securities - TLX 2 Jun 2023 8:19AM $11.660 $15.160 risen by 30.02%
$5,153 Securities Dealing Policy - updated 30 May 2023 8:19AM $11.110 $15.160 risen by 36.45%
$5,153 Results of Annual General Meeting 24 May 2023 2:35PM $11.535 $15.160 risen by 31.43%
$5,153 Annual General Meeting - Presentation 24 May 2023 10:30AM $11.690 $15.160 risen by 29.68%
$5,153 Annual General Meeting - Chairman and CEO Addresses 24 May 2023 10:29AM $11.675 $15.160 risen by 29.85%
$5,153 Notification regarding unquoted securities - TLX 5 May 2023 8:00AM $10.950 $15.160 risen by 38.45%
$5,153 Cleansing Notice 2 May 2023 8:16AM $10.460 $15.160 risen by 44.93%
$5,153 Application for quotation of securities - TLX 2 May 2023 8:16AM $10.460 $15.160 risen by 44.93%
$5,153 Cleansing Notice 1 May 2023 8:41AM $10.150 $15.160 risen by 49.36%

401 - 425 of 962 results

Page 17 of 39

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.